OMDA
Omada Health, Inc.
22.62
2 x 16.40
2 x 28.36
bid
ask
+
0.67
3.05%
2 @ 08:53 AM
22.48 -0.14 (0.62%)
| Ytd | 43.35% | |
| 1y | 23.95% |
22.04
day range
23.11
10.28
52 week range
26.91
| Open | 22.04 | Prev Close | 21.95 | Low | 22.04 | High | 23.11 | Mkt Cap | 1.34B |
| Vol | 1.40M | Avg Vol | 1.06M | EPS | -0.23 | P/E | N/A | Forward P/E | 47.47 |
| Beta | N/A | Short Ratio | 7.90 | Inst. Own | 81.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 16.94 | 200-d Avg | 17.14 | 1yr Est | 22.92 |
| Income Statement | |||
| Total Revenue | 78.05M | ||
| Revenues (USD) | 78.05M | ||
| Cost of Revenue | 29.36M | ||
| Gross Profit | 48.69M | ||
| Operating Expenses | 53.47M | ||
| Research and Development Expense | 12.70M | ||
| Selling, General and Administrative Expense | 40.78M | ||
| Operating Income | -4.78M | ||
| Interest Expense | 18.00K | ||
| Net Income | -2.97M | ||
| Net Income Common Stock | -2.97M | ||
| Net Income Common Stock (USD) | -2.97M | ||
| Consolidated Income | -2.97M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -2.95M | ||
| Earning Before Interest & Taxes (USD) | -2.95M | ||
| Weighted Average Shares | 58.92M | ||
| Weighted Average Shares Diluted | 58.92M | ||
| Balance Sheet | |||
| Cash and Equivalents | 211.77M | ||
| Cash and Equivalents (USD) | 211.77M | ||
| Trade and Non-Trade Receivables | 39.99M | ||
| Current Assets | 269.43M | ||
| Property, Plant & Equipment Net | 8.46M | ||
| Total Assets | 302.80M | ||
| Current Liabilities | 68.68M | ||
| Total Liabilities | 68.68M | ||
| Accumulated Retained Earnings (Deficit) | -459.71M | ||
| Shareholders Equity | 234.12M | ||
| Shareholders Equity (USD) | 234.12M | ||
| Assets Non-Current | 33.37M | ||
| Deferred Revenue | 29.35M | ||
| Goodwill and Intangible Assets | 15.22M | ||
| Inventory | 3.83M | ||
| Trade and Non-Trade Payables | 8.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.51M | ||
| Net Cash Flow from Financing | 3.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.27M | ||
| Capital Expenditure | -1.56M | ||
| Issuance (Purchase) of Equity Shares | 3.25M | ||
| Net Cash Flow from Investing | -1.56M | ||
| Net Cash Flow from Operations | -11.83M | ||
| Share Based Compensation | 4.21M | ||